Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xuya Wang
Observed name:
Xu-Ya Wang
Institutions:
Tianjin Medical University General Hospital,
Beijing Tsinghua Chang Gung Hospital
Observed institutions:
Tianjin Medical University General Hospital,
Beijing Tsinghua Chang Gung Hospital,
Daiichi Sankyo (United States),
Tianjin Medical University,
Tsinghua University
ORCID:
0000-0002-8342-8672
Observed ORCID:
0000-0002-8342-8672
OpenAlex ID:
A5080128841
PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma
2022
·
Xuya Wang
, Xisen Wang
, et al.
·
Cancer Gene Therapy
·
25
PDF
MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma
2021
·
Jin-Zhang Sun
, Jin-Hao Zhang
, et al.
·
Disease Markers
·
23
PDF
GPR65 contributes to constructing immunosuppressive microenvironment in glioma
2024
·
Jikang Fan
, Jie Liu
, et al.
·
Neurosurgical Review
·
10
PDF
629 Evaluation of immunomodulatory effects of ifinatamab deruxtecan (I-DXd) in the IDeate-Pantumor01 phase 1/2 study in patients with advanced solid tumors
2024
·
Xuya Wang
, Jasmeet Singh
, et al.
·
Journal for ImmunoTherapy of Cancer
·
3
Overcoming T-cell exhaustion in glioblastoma: A narrative review
2022
·
Xuya Wang
, Xisen Wang
, et al.
·
Glioma
·
3
Interrogation of macrophage-related prognostic signatures reveals a potential immune-mediated therapy strategy by histone deacetylase inhibition in glioma
2025
·
Xisen Wang
, Xuya Wang
, et al.
·
Frontiers in Oncology
·
1
PDF
Spatial enrichment of PTPRZ1 in the peritumoral niche drives glioblastoma migration via the OPA1/ROS/CDH2 axis
2026
·
Li Yi
, Shuhang Qin
, et al.
·
Journal of Translational Medicine
Show more works
View as search
Works count:
7
Citation count:
65
H-index:
3
I10-index:
3
Year
Topic
Type